معرفی
Andrew Forbes is a Professor of Biostatistics and Head of the Division of Quantitative Research Methodology at Monash University's School of Public Health and Preventive Medicine. His research focuses on statistical methodology for clinical trials, particularly cluster randomized trials, and their applications in healthcare. He leads the Biostatistics Collaboration of Australia and co-leads the Australian Clinical Trials Alliance Statistics Interest Group (ACTA-STInG).
He has been awarded Fellow of the Australian Academy of Health and Medical Sciences (2020) and twice received the Excellence in Trial Statistics award from ACTA (2021, 2022). His work contributes to UN Sustainable Development Goals related to health and well-being.
Key projects include the Flexible Stepped Wedge and Cluster Randomised Crossover Designs (2025-2028), Comprehensive Geriatric Assessment for perioperative care (2024-2029), and the CALIPSO trial on antimicrobial prophylaxis in cardiac surgery (2022-2027). He has collaborated on over 420 research outputs, emphasizing rigorous trial design, reporting standards, and innovative statistical methods.
